Hospiten Rambla University Hospital has taken a significant step towards innovation in healthcare with the installation of the Azurion R3 system, the first to be installed at Spain a few months ago and the first in the Canary Islands. Thanks to this new technology, interventional treatments reach a greater number of procedures for more patients in a consistent and efficient way. This advanced mechanism, recently launched to the market, incorporates the latest technological innovations, positioning this center at the forefront of minimally invasive care.
This was reported by Dr. Manuel Vargas, interventional cardiologist at Hospiten Rambla University Hospital, who pointed out that this new service is designed to "provide the best patient care quickly and reliably," regardless of the procedure being performed. "This system offers unprecedented capabilities in interventional treatment that, thanks to its intuitive platform optimizes workflow, making day-to-day life much simpler for healthcare professionals."
The Azurion R3 image-guided therapy system enables a wide range of routine and complex interventional procedures to be performed with ease and confidence. "Thanks to the unique user experience and its advanced capabilities, integrated with an
innovative system geometry, we will improve room throughput by providing a more accurate and efficient
superior care for our patients," he adds.
"Philips' close collaboration with innovation has enabled the Azurion R3 to have enhanced features, thanks to a renewed image, audio and video (VoIP) infrastructure that distributes external and internal video sources," he notes. In this regard, remote connectivity capabilities and cybersecurity enhancements "enable the transmission of unlimited system log files, ensuring continuous, secure and efficient operation."
Reaffirming commitment to innovation
Having the latest version of the platform in the areas of Cardiology, Radiology, Oncology and Interventional Neuroradiology of the hospital center, ensures the ability to update over time with the latest developments. Dr. Vargas affirms that "by having recently launched equipment on the market, we ensure that we have the latest technology available now and in the future. With this new interventional innovation, we reinforce our commitment to our patients, as we share a common goal: to effectively face today's challenges in order to be prepared now and always".
In addition, the cardiology specialist emphasizes the compatible applications from a single touchscreen located next to the table, "helping to make quick and informed decisions without breaking sterility." "As the interventional space evolves, systems, tools and new procedures continue to be connected to the platform to enhance the user experience."
Regarding these new interventional tools, Dr. Vargas notes that they not only allow for improved clinical outcome, but also reduce radiation doses received by patients and clinicians, as well as reduce contrast agent use. "With the use of the Dynamic Coronary Roadmap device, the number of angiograms can be reduced by approximately 26.3% and the volume of contrast by 28.8%. On the other hand, it allows procedures related to structural cardiac pathologies to be carried out, enabling the fusion of multimodality images with the image of the angiograph itself in an agile and automated manner," says the specialist.
"With the installation of this latest technology, Hospiten Rambla University Hospital reaffirms its commitment to innovation and excellence in healthcare, offering its patients the best solutions available on the market," he concludes.
This article is an English translation generated with Al from the original Spanish content. While we review content for clarity, the information is provided for general informational purposes only and should not be considered medical advice. Always consult a qualified healthcare professional for diagnosis or treatment.